PLIANT THERAPEUTICS, INC. Deferred Revenue Recognized
PLIANT THERAPEUTICS, INC. (PLRX) reported Deferred Revenue Recognized of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-16.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-03-16
- PLIANT THERAPEUTICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-06-30 was $0.00.
- PLIANT THERAPEUTICS, INC. contract with customer, liability, revenue recognized for fiscal 2019 was $0.00.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-11 | $0.00 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |